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Foxp3+ regulatory T cells (TR) are an immunosuppressive subset of CD4
+ T cells that maintain 
homeostasis of the immune system. They are sustained by the interaction between the Major 
Histocompatibility Complex (MHC) molecules present on antigen presenting dendritic cells and 
the T Cell Receptor (TCR) expressed on TR cells that is specific for the MHC loaded with an 
antigenic peptide. Here, we show that in addition to MHC/TCR interaction, Connexin-43 (Cx43) 
expression by dendritic cells is required to maintain the TR cell population. CD11c
+ dendritic cells 
represent a major subset of antigen presenting cells. Using flow cytometry, we have observed that 
mice which lack Cx43 expression in CD11c+ dendritic cells (Cx43DC-), have a lower percentage of 
TR cells which express lower levels of Foxp3. These mice showed increased incidence of 
dermatitis as they age, even though we show that their dendritic cells can efficiently present antigen 
to naive T cells using proliferation inhibition assay. The decrease in the proportion of TR cells were 
associated with an altered phenotype of these cells, demonstrated by lower expression of CD39 
and higher expression of CD73, ectonucleotidases mediating TR cell immunosuppressive function. 
We propose that the presence of Cx43 on the surface of dendritic cells is required for effective 
communication between TR cells and dendritic cells so as to sustain TR cell homeostatic expansion 
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Most multi-cellular organisms, if not all, face the constant threat of infection by a variety of 
microbial pathogens. The probability that the host organism will survive depends on its ability to 
overpower and eliminate the invading foreign material, by inducing defensive responses that are 
termed broadly as ‘immune responses’. Ideally, these responses target the pathogenic material and 
not the host cells and tissues. In this introduction, we will review antigen presentation by innate 
immune cells and the consequent activation of a few specific types of T cell subsets that play an 
important role in adaptive immunity and homeostasis. In addition, we will discuss the current 
understanding of the role of Connexin-43 in the immunological synapse, and how it relates to 
current research. 
 
1.1. Antigen presentation 
The first line of defense against foreign material is the physical and chemical barriers of the body 
like skin and antimicrobial enzymes secreted at mucosal surfaces, respectively. If foreign material 
or a pathogen were to successfully overcome the barriers and enter the body, the innate immune 
system responds to it in a multi-faceted way. Neutrophils, basophils, macrophages, monocytes, 
dendritic cells, natural killer cells and granulocytes bind foreign molecules through Pattern 
Recognition Receptors (PRRs), get activated and directly or indirectly facilitate the elimination of 
the pathogen (1-3). In most cases, the pathogen or what is referred to as antigen, is digested and 
destroyed by resident phagocytes. All phagocytic cells like macrophages/monocytes, granulocytes 




or take up large amounts of extracellular material through a process called pinocytosis and degrade 
the antigens that were endocytosed. Activated phagocytes secrete pro-inflammatory cytokines like 
Tumor Necrosis Factor-α (TNF-α), Interleukin-1 (IL-1), IL-6 and IL-18 and chemokines like 
CXCL-8 that recruit and activate cells of the adaptive immune system at the site of pathogen entry 
(4, 5).  
One of the main roles of phagocytes is to present antigenic peptides on the cell's surface in order 
to activate cytotoxic and helper T cells of the adaptive immune system. T cells are not able to 
recognize native antigens and conformational epitopes; therefore, they depend on recognition of 
processed antigen for activation. Antigen processing relies on proteolytic digestion of ingested 
proteins/antigens and binding of resulting peptides to the Major Histocompatibility Complex 
(MHC) molecules. MHCs are polymorphic transmembrane glycoproteins found on the cell's 
surface having a characteristic peptide-binding groove. MHC structure is stabilized by binding 
peptides derived from self or exogenous proteins.  There are two types of MHC molecules. MHC 
Class I (MHCI) molecules are expressed by all nucleated cells and present antigenic peptides to 
cytotoxic CD8+ T cells (6). It increases the targeting of abnormal cells by CD8+ cytotoxic T cells 
that recognizes the mutated peptides, like those resulting from DNA damage or cancer associated 
mutations (7). MHC Class II molecules are only present on phagocytic cells, of which 
macrophages and dendritic cells are referred to as "professional antigen presenting cells" (8). When 
the endocytosed material is broken down in acidified endosomes, it is loaded onto the MHCII 
molecule and transported to the cell membrane for antigen presentation. The helper CD4+ T cells 
require this presentation of antigenic peptide in the context of MHCII molecules in order to be 
activated (9). CD11c is a type I transmembrane protein that is constitutively present on all dendritic 




used in this study to identify the dendritic cell population, which are known to be efficient 
activators of regulatory T cell population. This is further discussed in 1.3. 
 
1.2. Development and activation of CD4+ T cells 
The adaptive immune responses are carried out by B and T lymphocytes, two types of white blood 
cells that are differentiated from hematopoietic stem cells in the bone marrow. B cell 
differentiation occurs in the bone marrow, and T cell maturation takes place in the thymus. B cells 
and T cells have a large repertoire of B cell receptors (BCRs) or T cell receptors (TCRs) to enable 
these cell types to detect and eliminate a variety of pathogens (10). A TCR is a dimer and consists 
of one α and one β chain, each having a variable and a constant region. The variable regions of 
these chains have a unique sequence that can bind to a peptide in complex with an MHC molecule. 
In this way, T cells are MHC-restricted and cannot be activated by antigenic peptide alone. The 
development of T cells or thymocytes takes place in the thymus and is a very systematic process 
that ensures a low probability of self-reactivity. After the successful rearrangements of the V, D 
and J gene segments of the TCR’s β-chain takes place, there is a rapid clonal expansion of the cells 
whose β-chain was successfully rearranged, accompanied by the expression of co-receptor proteins 
CD4 and CD8 that have the role of binding to a portion of the MHC Class II and MHC Class I 
molecule, respectively, to infer stability of the eventual TCR/MHC interaction (11, 12). The cell 
proliferation is followed by α-chain rearrangement in each individual cell (13).  The next step in 
ensuring that these cells will bind to an MHC molecule is called positive selection where thymic 
cortical epithelial cells express MHC molecules for thymocytes to bind, and during this step, the 
T cell will commit to expressing either CD4 or CD8 depending on the strength of the affinity by 




step undergo apoptosis. During negative selection, any thymocyte that binds with high affinity to 
an MHC molecule with a self-antigen peptide is eliminated by apoptosis (15). This significantly 
reduces the chance of auto-reactive T cell clones. Elimination of self-reactive T cells is 
complemented by a dominant tolerance mechanism relying on the presence of suppressor CD4+ T 
cells. These cells, called natural regulatory T cells (TR), expressing transcription factor Forkhead 
box P3 (Foxp3) are generated in the thymus and recognize MHCII + self-peptides. Current data 
support the conclusion that TR cells are generated in an instructive process when interactions 
between TCR and MHCII/peptide complex, stronger than that of conventional CD4+ thymocytes, 
induce Foxp3 expression and launch a genetic program of TR cell differentiation (16). 
Immunosuppressive role of TR cells relies on various mechanisms and depends on recognition of 
a self-peptide on MHCII molecule, which is further discussed in 1.3. The CD4+ Foxp3+ TR 
thymocytes migrate out of the thymus and circulate to the lymphoid tissues through the blood 
stream. Professional antigen presenting cells like dendritic cells migrate to the lymphoid tissues to 
interact with circulating naïve CD4+ conventional and TR cells (17). These could be CD11c
+ 
migratory Langerhans cells or dermal dendritic cells that reside in the skin and sample antigens 
(18).  When the naïve CD4+ T helper cell recognizes the specific antigen presented by a dendritic 
cell and co-stimulatory molecules, the T cell remains in the lymphoid tissue and undergoes clonal 
expansion with the production of cytokines that gives rise to effector T cells and memory T cells. 
The naïve and effector T cells migrate out of the lymph node and move toward the site of infection 
by chemotaxis. The CD4+ T cells recognize antigen presented by APC at the site of infection, get 
activated and undergo clonal expansion and cytokine production (19). Depending on the cytokines 
in the environment, the effector T cells differentiate into subsets like T helper 1 (TH1) cells that 




secrete IL-17 (22) or peripheral regulatory T (TR) cells that secrete IL-10, as depicted in Fig. 1 
(23), and upregulate the expression of characteristic transcription factors and cytokines. TH1, TH2 
and TH17 cells release pro-inflammatory cytokines, whereas TR performs an immunosuppressive 




Fig. 1. Naïve T cells differentiate on activation based on the cytokines in its environment. 
Animated drawing depicting TCR/MHC interaction between an APC and CD4+ T cell through 
MHC-II; and interaction between the APC and CD8+ T cell through MHC-I. Based on the 
cytokines in the environment, the effector T cells differentiate into effector cells with pro-
inflammatory, anti-inflammatory or cytotoxic roles specified within the orange boxes. The yellow 






1.3. Immunosuppressive CD4+ Foxp3+ regulatory T cells 
Maintenance of immune tolerance is largely carried out by CD4+ Foxp3+ TR cells. Gene mapping 
and functional studies established that Foxp3 is an X-chromosome-encoded gene and a master 
regulator of CD4+ TR cell development in both humans and mice. Foxp3-deficient mice do not 
have functional TR cell population and develop fatal lymphoproliferative autoimmune syndrome 
at 3-4 weeks of age (24). TR cells constitute up to 10-20% of the CD4
+ T cell compartment. Like 
other CD4+ T cells, CD4+ Foxp3+ TR cell population’s development and activation are strictly 
dependent on the TCR/MHC interactions (25).  
All APCs, expressing class II MHC molecules, have the ability to induce antigen specific CD4+ 
Foxp3+ TR cells in the presence of IL-2 and TGF-β. However, there is evidence that dendritic cells 
(DCs) are the most efficient activators of TR cells (26). In the presence of high concentrations of 
IL-2, the apoptotic signaling in TR cells is inhibited. On recognition of the MHC/peptide 
complexes through their TCR, TR cells undergo clonal expansion and make direct contact or 
produce effector molecules to enforce immune suppression. Some of the molecules by which these 
TR cells maintain homeostasis have been outlined in Table 1 (27). Foxp3
+ Regulatory T cells can 
be immunosuppressive in an antigen non-specific manner in multiple ways. Through the secretion 
of cytokines like TGF-β and IL-35 by TR cells, CD4
+ effector cells are led to differentiate into 
immunosuppressive Foxp3+ cells as discussed in 1.2 (28, 29). Other cytokines like IL-10 have 
been shown to be required for effective immunosuppression at interfaces like the colon and lungs 
(30). Regulatory T cells are also able to transfer cyclic-AMP (cAMP) into conventional cells in a 
contact-dependent manner through gap junctions to result in the induction of the expression of the 
transcription factor ICER (Induced Cyclic-AMP Early Repressor) in conventional CD4+ T cells. 




activated CD4+ T cells (31).  CD39 is an ectonucleotidase present on the surface of Foxp3+ TR 
cells, that converts adenosine diphosphate (ADP) or adenosine triphosphate (ATP) to adenosine 
monophosphate (AMP), where ATP is a known mediator of inflammation. CD73 is also an 
ectonucleotidase on the TR cell whose function complements CD39 and converts AMP to 
adenosine which has been shown to have an immunosuppressive role (32). TR cells can also 
maintain homeostasis by secreting cytolytic molecules like granzymes and perforin to induce 
apoptosis in conventional CD4+ T cells (33). Certain dendritic cells express indoleamine 2,3-
dioxygenase (IDO) that catalyzes the degradation of tryptophan to kynurenine which starves the 
effector T cells and puts them in cell cycle arrest. Via CTLA-4-induced signaling, TR cells can 
increase IDO expression in dendritic cells and also direct TR differentiation of naïve CD4




Table 1. Immunosuppressive effector molecules of TR cells. The known effector molecules of 
TR cells can be classified into secreted immunosuppressive cytokine molecules, molecules that 
inhibit metabolic signaling, secreted cytolytic molecules and membrane associated molecules that 
inhibit T effector cell activation. 
IL- interleukin; TGF-β- Tumor growth factor β; FGL2- Fibrinogen-like protein; cAMP-inhibitory 
second messenger cyclic AMP; NAD- nicotinamide adenine dinucleotide as metabolized by CD38 
and operative at P2X7; TRAIL-DR5 (tumor-necrosis-factor-related apoptosis-inducing ligand-
death receptor 5); CTLA-4- Cytotoxic T-Lymphocyte Antigen 4; LAG-3- Lymphocyte-activation 










TGF-β cAMP Granzyme A/B CTLA-4 
IL-10 CD39 Perforin LAG-3 
IL-35 CD73 TRAIL-DR5  






 As a result of the effects of these molecules and direct interactions, activated T cells and antigen 
presenting cells are not able to carry out their immunological response effectively. TR cell 
population consumes a large portion of IL-2 produced by the activated CD4+ T cells and in doing 
so, carries out IL-2 deprivation and induces apoptosis of both cell populations (35). For this reason, 
TR cell populations were initially identified by the expression of CD25, which is the α-chain of the 
IL-2 receptor. However, the upregulation of CD25 on all activated CD4+ cells and the existence 
of non-immunosuppressive CD4+ CD25+ cells were observed, and Foxp3 expression was found to 
be a more precise marker for the immunosuppressive cells (24). Immunoregulation is an essential 
process in order to avoid potentially damaging autoimmune responses by non-regulatory T cells 
and to maintain tolerance to self-antigens. CD4+ Foxp3+ TR cells have a high turnover rate and 
respond to a range of signals from the environment that may make them anergic or persist as 
memory cells (36). Therefore, maintenance of a stable population size of functional TR is required 




Connexins are a family of small transmembrane proteins that assemble into membrane complexes 
to create small channels called gap junctions in order to allow communication between cells or 
carry out paracrine functions as hemi-channels (37, 38). Connexin-43 (Cx43) has a relatively long 
cytoplasmic domain with a number of phosphorylation sites that have been proposed to interact 
with cytoskeletal elements and signaling molecules like protein kinase C, mitogen-activated 
protein kinase and β-catenin (39). Recent evidence has shown that Cx43 may have the ability to 




cells like dendritic cells, monocytes, B cells, T cells and Natural Killer cells (41). On antigen 
activation, expression of Cx43 is upregulated in T cells (42). Hemi-channel function of Cx43 is 
pro-inflammatory as it involves the release of ATP, a mediator of inflammation (43). In contrast, 
channels can form at gap junctions between effector and TR cells to facilitate the transfer of cAMP 
from TR cells to effector cells (31). In summary, modulating connexin-43 expression or gap 
junction formation may alter the course of adaptive immune response mediated by T cells.  When 
the hemi-channel activity of Cx43 was reduced while simultaneously promoting gap junction 
plaque formation using a mimetic peptide- αCT1 in a non-obese diabetic mouse model, TR 
suppressor ability was partially restored (44). Phase III clinical trials of the use of αCT1 for wound 
healing during treatment of diabetic foot ulcers is currently underway (45). Additionally, higher 
expression of Cx43 has been observed in human and murine thymic epithelial cells (42). Although 
the mechanism of its function has not been elucidated, several reports conclude that Cx43 is a 
component of the immunological synapse. 
 
1.5. Purpose of research and experimental design 
To examine the role of gap junctions and communication between TR cells and DCs, we used a 
mouse model in which Gja1 gene that codes for Cx43 was knocked out in CD11c+ dendritic cells 
alone. Several of these mice spontaneously developed dermatitis and a preliminary experiment 
showed a reduction in the number of CD4+ Foxp3+ TR cells in both the lymph nodes and spleens 
of the Cx43DC- mice. This provided the initial motivation for the study of the role of connexin in 
maintaining the regulatory T cell population. This research contributes to the literature on the 
involvement of Cx43 in the maintenance of regulatory T cell population, with the hope of shedding 




caused in mice due to the lack of expression of Cx43 in dendritic cells. For this reason, phenotypic 
and functional analyses of peripheral populations of DC and CD4+ T cells using flow cytometry 
were carried out. Flow cytometry data on the dendritic cell population in the skin of wild-type 
(WT) control mice and Cx43DC- mice were also analyzed. The ability of the CD11c+ dendritic cells 
with no expression of Cx43 to activate CD4+ naïve T cells and the ability of their TR cells to 
suppress proliferation of activated CD4+ T cells were measured through radioactive thymidine 
















2.1. Generation of Cx43DC- mice 
Conditional knockout of Gja1 gene that codes for Connexin-43 (Cx43loxP) were crossed with 
CD11ccre and Foxp3GFP reporter mice (39, 46). These mice were compared to wild-type control 
mice during analyses. Mice were housed and sacrificed according to the guidelines of the 
Institutional Animal Care and Use Committee of Old Dominion University under IACUC protocol 
number 17-017.  Subsequent cell work was carried out with the approval of the Institutional 
Biosafety Committee of Old Dominion University under IBC protocol number 19-007. 
 
2.2. Isolation of dendritic cells from the skin 
Dorsal skin from the mice were cut and incubated in 0.5 mL of 0.2 mg/mL Dispase I solution in a 
24-well plate overnight at 4oC. Hair was removed and incubated at 37oC in 1 mL Collagenase IV-
DNase solution (RPMI, 10% FBS, 1.5 mg/mL Collagenase IV and 0.5 mg/mL DNase) followed 
by addition of 1mL of Collagenase IV-DNase solution every 30 minutes for 2 hours. The solution 
was then filtered and centrifuged at 1200 rpm for 6 minutes. The pellet was resuspended in PBS + 
2% FBS for antibody staining and subsequent flow cytometry analysis. 
 
2.3. Cell purification, flow cytometry and cell sorting 
Lymph nodes and spleens of Cx43DC- and WT mice were isolated and passed through nylon mesh 
to form cell suspensions in PBS + 2% FBS. Spleen suspensions were centrifuged at 1200 rpm for 




sample. This sample was incubated at room temperature for 6 minutes and centrifuged at 1200 
rpm and resuspended in PBS + 2% FBS. Aliquots of the cell suspension were stained with eight 
color antibody sets with antibodies specific for CD4, CD8, CD44, CD62L, 4-1BB, Tim-3, PD-1, 
IL-7R,Klrg-1, BTLA, Lag3, CD25, CD39, CD73, Sirp1α, CD80, 4-1BBL, MHCII, CD24, CD86, 
PDL1, F4/80, Ox40L and Gr1 (BD Bioscience, BioLegend, eBioscience) for 30 minutes at 4oC 
with subsequent washes with PBS + 2% FBS, and analyzed using a flow cytometer 
(BDFACSCanto). CD4+ cells were negatively selected using streptavidin beads (mentioned in 2.4), 
while CD11c+ cells were positively selected using PE magnetic beads (mentioned in 2.5). In 
addition to this, these cells were sorted from the cell suspensions using a flow cytometer (BD 
Influx) for increased purity of 98-99%. 
 
2.4. Negative selection of CD4+ cells using streptavidin beads. 
Cell pellets were resuspended in 150 L of PBS + 2% FBS and stained with biotinylated antibodies 
against CD8, Ter119, B220, CD49b (BD Bioscience, BioLegend, eBioscience) for 30 minutes at 
4oC. After a wash with PBS+ 2%FBS, the cells were incubated with streptavidin magnetic beads 
(Appendix) for 20 minutes at 4oC, and the tube was placed in a magnet for 6 minutes. The clear 
solution was carefully pipetted out, centrifuged at 1200 rpm for 6 minutes and resuspended in PBS 
+ 2% FBS as a CD4+ sample. Purity of the sample was checked using flow cytometry.  
 
2.5. Positive selection of CD11c+ cells using PE beads. 
Cell pellets were resuspended in 150 L of PBS + 2% FBS and stained with CD11c-PE antibody 
for 30 minutes at 4oC, followed by a wash with PBS + 2% FBS. The cells were incubated with PE 




% FBS and loaded into the column attached on a magnetic plane. The flow through was disposed, 
and the column was detached from the magnet. PBS + 2% FBS was used to flush the CD11c+ cells 
into a collection tube. Purity of the sample was checked by flow cytometry. 
 
2.6. Proliferation assay 
In a 96-well round bottomed plate, 3x104 sorted CD11c+ DCs and 2x104 CD4+ cells from a 
transgenic mouse whose CD4+ T cells are specific for a peptide PCC50V54A were stimulated with 
soluble peptide (5 M) in CTM (Appendix) and incubated at 37oC with 5% CO2. Three days after 
stimulation, 1 Ci/well of 3H-thymidine was supplied. The radioactivity of the resulting cells after 
washing were measured on Tri-Carb 3110TR Liquid Scintillation Analyzer. 
 
2.7. Proliferation inhibition assay 
In a 96-well round bottomed plate, 5x104 sorted naïve (CD44lo CD62Lhi) CD4+ T cells and 5x104 
WT DCs from lymphopenic mice (TCRα-) were stimulated using antibody against CD3 (BD 
Bioscience- 3 g/mL) in CTM (Appendix) and incubated at 37oC with 5% CO2. In different wells, 
TR were added in increasing concentrations of 0%, 5%, 10% 20% and 40% of total naïve CD4
+ T 
cells. After three days of stimulation, 1 Ci/well of 3H-thymidine was added, and radioactivity of 
the sample after washing was measured on Tri-Carb 3110TR Liquid Scintillation Analyzer. 
 
2.8. Data analysis 
Flow Cytometry data was analyzed in dot plots and histograms using FlowJo v10. The results of 








3.1. Development of dermatitis in Cx43DC- mouse 
The Cx43DC- mice, having a lack of expression of Connexin-43 in CD11c+ dendritic cells, seem to 
visually develop normally apart from the dermatitis observed. About 25% of mice aged 1 to 4 
months begin to develop a form of dermatitis on their dorsal skin (Fig. 2), which is first seen as 
barbering. Moreover, 60% of the mice older than 5 months had dermatitis progressing from 
barbering to open skin lesions. This skin disease is likely caused by an autoimmune response that 
has been sustained due to lack of immune suppression. During an auto-immune response, the TR 
population is usually lower than in healthy mice. Lymph nodes and spleens were isolated from 
these mice and T cell populations were analyzed to further investigate the cell populations affected 








Fig. 2. Cx43DC- mice spontaneously develop dermatitis. Image of barbering seen on the dorsal skin 





3.2. Dendritic cell population density in the skin of Cx43DC- mice varies compared to that of wild-
type control mice 
To investigate the changes in skin’s dendritic cell population due to the lack of Cx43 on CD11c+ 
DC cells, skin was digested, and the cells were isolated to be stained. There was a presence of 
CD11c+ MHCII+ CD24- CD103- dermal DCs in young 2-month old Cx43DC- mice, which was 
barely detectable in control mice (Fig. 3). These cells are usually only detectable at 3 months of 
age as the immune system matures. It is possible that the existence of larger proportion of dermal 
dendritic cells that are migrating to the skin, is the reason why Cx43DC- mice are predisposed to 
developing skin disease. The CD11c+ MHCII+ CD24+ CD11b+ Langerhans cell population was 
increased in Cx43DC- mice with respect to age, whereas CD11c+ MHCII+ CD24+ CD11b- dermal 
dendritic cell population was decreased, also with respect to age compared with age-matched WT 








Fig. 3. Increased presence of dermal dendritic cells in the dorsal skin of 2 month old Cx43DC- mice.  
Mice lacking Cx43 expression by CD11c+ dendritic cells have a larger proportion of CD24- 
CD103- dermal dendritic cells in the dorsal skin of 2 month old mice. Dermal dendritic cells usually 
are present in low numbers in the skin till 3 months of age when the immune system is mature. 
 
 
3.3. Increased activation is seen in older Cx43DC- mice with dermatitis. 
The flow cytometry data analysis of cells from lymph nodes showed that in Cx43DC- mice with 
dermatitis, more than 70% of the CD4+ cells in the lymph nodes were activated, depicted as 
CD44hiCD62lo cell population in Fig. 4. These activated cells from Cx43DC- mice had a decrease 
in activation markers 4-1BB and Klrg1 expression, accompanied by an increase in inhibitory 
molecule PD-1 in old mice, compared to age-matched WT (Fig. 5). The changes in population of 
activated cells and expression of activation markers shown in Fig. 4 and 5 were not seen in Cx43DC- 




attributed to the response to the dermatitis seen on the dorsal skin, while the changes in expression 






Fig. 4. Increased activation in Cx43DC- mice with dermatitis. Total CD4+ cells can be separated 
into activated and naïve cells based on the expression of CD44 and CD62L. The plots show that 





















Fig. 5. Changes in expression of molecular markers for activation and inhibition in activated cells 
of Cx43DC-. Histograms showing the expression of 4-1BB, PD-1, IL-7R, Klrg1, Lag3 and BTLA 
by activated CD4+ CD44hiCD62lo cells of WT and Cx43DC- mice. 
 
 
3.4. Decrease of CD4+ Foxp3+ TR population in Cx43
DC- mice with relation to age. 
Using flow cytometry, we analyzed the different T cell populations in the lymph nodes of the 
knockout mice alongside age-matched controls. We found that Cx43DC- mice had a smaller 
population of CD4+ Foxp3+ TR cells compared to WT mice (Fig. 6, 7). Additionally, these TR cells 
expressed Foxp3 with a lesser intensity (Fig. 8) as indicated by the decrease in mean fluorescence 
intensity measurement of the fluorophore by flow cytometry. The lower amounts of 
immunosuppressive regulatory T cells may have led to the development of dermatitis seen among 







Fig. 6. Lower CD4+ Foxp3+ TR cell population in Cx43
DC- mice. Flow cytometry analysis of Foxp3 
expression by gated CD4+ Foxp3+ cells showing that Cx43DC- mice had lower proportion of Foxp3+ 




Fig. 7. Decrease in CD4+ Foxp3+ TR population in Cx43
DC- mice with respect to age. The 
percentage of TR cells in lymph nodes of Cx43
DC- mice decrease with respect to age categorized 













Fig. 8. Decrease in Foxp3 expression of CD4+ Foxp3+ TR cells in Cx43
DC- mice with respect to 
age. Mean fluorescence Intensity of Foxp3 expression of the TR cells of Cx43
DC- mice is also 
reduced, portraying a reduced expression of Foxp3 at 1-3 months of age and greater than 8 months 
of age based on flow cytometry data.  
 
 
3.5. An altered phenotype of CD4+ Foxp3+ TR is observed in Cx43
DC- mice.  
As mentioned earlier, CD39 and CD73 are ectonucleotidases on the surface of Foxp3+ regulatory 
T cells. Flow cytometric data analysis of Foxp3+ TR cells of Cx43
DC- mice showed that a large 
majority of the cells took on a CD39+ CD73+ phenotype (Fig. 9), unlike the populations of different 
level of expressions seen in WT mice. This population also had a decrease in CD39 expression 








Fig. 9. Majority of CD4+ Foxp3+ cells of Cx43DC- mice have acquired CD39+ CD73+ phenotype.  
Flow cytometry data that shows that more than 90% of CD4+ Foxp3+ TR cells from Cx43
DC- mice 
have acquired CD39+ CD73+ phenotype at young (2 months) and old (12 months) age compared 








Fig. 10. CD4+ Foxp3+ TR cells of Cx43
DC- mice have altered expression of CD39 and CD73. The 
CD4+ Foxp3+ CD39+ CD73+ TR population gated in Fig. 7 displays varied expressions of CD39 
and CD73 among Cx43DC- and WT. There is reduced expression of CD39 and increased expression 
of CD73, measured by flow cytometry in both young and old mice. 
 
 
3.6. CD4+ Foxp3+ TR cells from Cx43
DC- mice suppress the proliferation of CD4+ cells. 
It was proposed that presence of CD4+ Foxp3+ CD39+ CD73+ with altered phenotype might off-
set the conversion of pro-inflammatory ATP to immunosuppressive adenosine and be responsible 
for a possible lack of immune suppression leading to the dermatitis seen on the mice. To check 
this, we set up a proliferation inhibition assay with APCs and CD4+ naïve T cells along with 
increasing proportions of CD4+ Foxp3+ TR cells. The splenocytes were taken from TCRKO mice 
which did not have functioning T cells, and used as APCs in this assay. Soluble CD3 antibody was 
supplied to ensure activation of the CD4+ naïve T cells. The amount of tritium labelled thymidine 
(3H-thymidine) incorporated was used to measure proliferation of the cells. The results from this 
experiment show that the CD4+ Foxp3+ cells from the Cx43DC- mice suppressed the proliferation 




slight decrease, as the readings were within one standard deviation of the WT and considered not 
significant (Fig. 11). Although the phenotype of the regulatory cells developed in Cx43DC- mice 
had altered levels of CD39 and CD73 expression, perhaps they were able to suppress using 




Fig. 11. Proliferation inhibition assay results. Data from the scintillation counter showing the 




3.7. Prominent CD4+ Foxp3- CD25+ cell population is seen in Cx43DC- mice 
Flow cytometry analysis showed that WT mice have less than one percent of Foxp3- CD25+ cells 
at 2 months and at 12 months, whereas Cx43DC- have about 4% at 2 months and about 10% when 
they are 12 months or older (Fig. 12). CD25 is the IL-2 receptor required for differentiation into 
CD4+ Foxp3+ TR cells in the presence of IL-2. There is a possibility that Foxp3
+ cells lose their 
Foxp3 expression while still expressing CD25 but are not immunosuppressive. Increased 




of connexin gene in double positive thymocytes. Increased proportion of this population in 
Cx43DC- mice indicates that there is impaired communication between TR and DC cells that affects 
TR cell stability in the peripheral tissues. Thus, transition of Foxp3
+ cells to Foxp3- CD25+ cells 
could be the cause for decreased proportion of CD4+ Foxp3+ TR population in Cx43
DC- mice. Cx43 
expression by dendritic cells may be involved in triggering CD4+ Foxp3+ T cells that do not lose 




Fig. 12. Prominent presence of CD4+ Foxp3- CD25+ cells in Cx43DC- mice. Age-matched WT and 
Cx43DC- have differing proportions of CD4+ Foxp3- CD25+ cells shown by flow cytometry at 




3.8. CD11c+ dendritic cells from Cx43DC- mice can present antigen effectively 
CD11c+ dendritic cells sorted from WT or Cx43DC- mice were added to a well with CD4+ naïve T 
cells sorted from a mouse with transgenic TCR for a peptide PCC50V54A in a proliferation assay. 
After four days of incubation with the peptide, 3H-Thymidine was added. The incorporation of 3H-
Thymidine was used to measure proliferation of CD4+ that were successfully activated by CD11c+ 
dendritic cells. Fig. 13 shows that CD4+ T cells activated by DCs from Cx43DC- mice proliferate 
more vigorously than the same cells activated by wild type dendritic cells. This data shows that 
inhibition of communication between TR cells and DCs also affect DCs by making them more 
effective antigen presenting cells. This further suggests that TR cells modulate antigen presenting 
cells. Enhanced function of antigen presenting cells in Cx43DC- mice likely affects organs which 
are exposed to contact with environment like skin and gut airways. Enhanced responses to antigen 
could be a factor that promotes the skin inflammation observed in Cx43DC- mice.  In the current 




Fig. 13. Proliferation assay results. Data from the proliferation assay with CD11c+ APCs from WT 
and Cx43DC- mice with CD4+ T cells from transgenic mice specific for peptide PCC50V54A. 3H-
























4.1. Cx43 expression by CD11c+ dendritic cells maintains CD4+ Foxp3+ cell population 
Lack of Cx43 expression in CD11c+ dendritic cells alone resulted in decrease in population of 
CD4+ Foxp3+ TR, and a possible formation of dermatitis on the dorsal skin of the mouse. These 
findings support that of Yamazaki et al. (2003) in that it confirms that CD11c+ dendritic cells 
maintain the TR population (26). However, our data shows that in addition to the interactions 
between TCR on TR cells and MHC on DCs are important for both cell populations and that the 
communications through gap junctions is most likely required for sustaining functions of both 
cell subsets.  
CD25 is the IL-2 receptor required for differentiation into TR cells. A prominent population of 
CD4+ Foxp3- CD25+ cells were seen in the lymph nodes of Cx43DC- mice. An explanation could 
be that the TR cells that were formed in the periphery during activation lose their Foxp3 
expression and may assume features of exTR cells (47, 48). These cells are known to produce 
pro-inflammatory cytokines and promote autoimmune diseases. It is currently not known what 
promotes loss of Foxp3 and generation of exTR cells. It is possible that the loss of Foxp3 by TR 
cells, and thereby its immunosuppressive function, is the reason for the increase in proliferation 
seen in the proliferation assay where CD11c+ DC from Cx43DC- mice presented PCC50V54A 
antigen to CD4+ naïve T cells. In case of TR cells that interacted with the peptide + MHCII on 
CD11c+ DC that did not have Cx43 for proper signaling, TR cells may not receive some, at 




expression.  At the same time, Cx43 deficient DCs also loose TR cell mediated tonic signal which 
conditions these cells to be over-stimulatory. Overtime, lack of interactions between DCs and TR 
cells which involve Cx43 affects both populations altering their response to homeostatic 
interactions and antigenic stimulation.  
We hypothesized that the CD4+ Foxp3+ TR cell from Cx43
DC- mice were not able to suppress 
proliferation due to the changes in CD39 and CD73 expression which may offset the conversion 
of pro-inflammatory ATP to immunosuppressive adenosine. However, the results of the 
proliferation inhibition assay show that these TR cells suppressed the proliferation of activated 
CD4+ T cells with only a slight decrease in immunosuppressive function. However, the 
proliferation inhibition assay used to examine the suppressor function of TR cells from Cx43
DC- 
mice may not be the most suitable assay. This was the first assay used to probe TR cell function 
in vitro and there has been multiple examples when the short term suppressor function of TR cells 
is preserved in vitro but in vivo functions are impaired.  
Taken together, our results show that lack of Cx43 expression by dendritic cells does not affect 
the ability of these cells to present antigen to CD4+ naïve T cells and activate them. However, the 
CD4+ Foxp3+ population was significantly reduced. Knowing that dendritic cells maintain the TR 
cell population (26) and that Cx43 signaling enhances the generation of Foxp3+ TR cells (39), we 
propose that Cx43 expression by CD11c+ dendritic cells is required for maintaining CD4+ 







4.2. Future Research 
It is possible that CD11c+ DC interact with an intermediary component that directly or indirectly 
maintain the TR cell population, but there is no evidence of such a component as of now. We 
were not able to test the antigen-specific activation of regulatory T cells by antigen presenting 
cells because TR cells with transgenic TCR do not make it through thymic selection. Thus, we 
were unable to run an in vitro test of aspects of the interaction between APC and antigen specific 
TR cells. The findings of a study like this would be of great importance to our proposal of the 
role of Cx43.  
Cx43 is undeniably a part of the immunological synapse and this has been proposed by multiple 
research studies. The results of application of αCT1, a mimetic peptide of Cx43, to increase 
wound healing mentioned earlier is a big example of this association. Our results implicate gap 
junction protein, Cx43 in the communication between CD11c+ dendritic cells and CD4+ Foxp3+ 
TR cells. It is possible that Cx43 is used by CD4
+ effector T cells or CD4+ Foxp3+ T cells to 
execute their immunological roles and this could be a topic of interest for future research. In 
addition, it is very likely that Cx43 is not the only connexin involved in maintaining regulatory T 
cells. Furthermore, looking into the Cx43 signaling pathway may shed some light onto the 
precise changes taking place at a molecular level that leads to maintenance of regulatory T cells.  
Undeniably, understanding the cells that use or require Cx43 to directly or indirectly control 
auto-immune responses will open up pathways for targeted therapies that may correct one of the 
underlying factors of autoimmune diseases which is the low amount of CD4+ Foxp3+ TR at the 








In the Cx43DC- mouse model, Connexin-43 molecule is not expressed by CD11c+ dendritic cells 
and a higher probability of developing dermatitis was seen in these mice. The low population of 
TR in these mice, support the notion that the skin disease may be autoimmune in nature. The ability 
of CD11c+ dendritic cells to present antigen to naïve T cells were not affected by the loss of Cx43. 
However, the drastic decrease in TR cell population and Foxp3 expression, combined with the 
altered CD39+ CD73+ phenotype, indicate that Cx43 is an important player in the communication 
between antigen presenting cells and the TR cell subset. These results also suggest that TCR/MHC 
interaction along with defined co-stimulatory processes are not enough in itself, but require Cx43 
expression by CD11c dendritic cells, to maintain immunosuppressive CD4+ Foxp3+ TR cell 
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NaCl 8g, KCl 400mg, CaCl2 140mg, MgSO4.7H20 100mg, MgCl2.6H2O 100mg, 
Na2HPO4.2H2O 60mg, KH2PO4 60mg, Glucose 1g, NaHCO3 350mg, MiliQ added up to 1L. 
 
Collagenase IV (Worthington) 
 
Complete Freund’s Adjuvant (CFA) (Sigma-Aldrich) 
Mixed with 1x PBS at 1:1 before administration 
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αMEM 500mL, “tumor cocktail” 50mL, FBS 50mL, L-glutamine (200mM) 5mL. 
Tumor cocktail- αMEM 630mL, dextrose 7.5g, essential amino acids 50x (Cellgro) 200mL, 
endogenic amino acids 100x (Cellgro) 100mL, Sodium pyruvate 100x (Cellgro) 100mL, adjust 
pH to 7.0, NaHCO3 8.5g, Gentamycin (Gemini Bioproducts) 0.5g, Penicillin G 0.6g, 
Streptomycin 1g, β-mercaptoethanol 34uL. 
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APC-Cy7  CD4 CD8 CD62L    
Biotinylated  CD8 CD39 CD49b 4-1BB Klrg1 Ter119 
BV421  CD8 CD25     
BV510  CD4      
FITC  MHCII      
PE  CD4 CD11c CD44 CD73   
PE-Cy5  CXCR3 IL-7R CD4    
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